A recent theory about the basis for fragile X syndrome is now validated in a mouse model. The findings point the way to treatment options targeting group 1 metabotropic glutamate receptors.

“The sooner a child with Fragile X syndrome gets treatment, the more opportunity there is for learning.” From news to politics, travel to sport, culture to climate – The Independent has a ...